KEROS THERAPEUTICS INC has a total of 40 patent applications. It decreased the IP activity by 61.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SYNERGEN INC, ALEXO THERAPEUTICS INC and NOVOZYMES BIOPHARMA UK LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 6 | |
#3 | Canada | 6 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | United States | 6 | |
#6 | China | 5 | |
#7 | Republic of Korea | 3 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Climate change adaptation technologies | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Lachey Jennifer | 39 |
#2 | Seehra Jasbir S | 31 |
#3 | Seehra Jasbir | 8 |
Publication | Filing date | Title |
---|---|---|
WO2020086730A1 | Alk2 antibodies and methods of use thereof | |
AU2019266314A1 | Activin receptor type iia variants and methods of use thereof | |
AU2019206634A1 | Activin receptor type IIB variants and methods of use thereof | |
US2021030841A1 | Activin receptor type iia variants and methods of use thereof | |
AU2018364668A1 | Activin receptor type lla variants and methods of use thereof | |
AU2017357931A1 | GDNF fusion polypeptides and methods of use thereof | |
CN110461349A | Activin receptor IIA type variant and its application method |